PubMed Journals Articles About "Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed" RSS

17:04 EST 8th December 2019 | BioPortfolio

Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed articles that have been published worldwide.

More Information about "Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed" on BioPortfolio

We have published hundreds of Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed news stories on BioPortfolio along with dozens of Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed Clinical Trials and PubMed Articles about Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed Companies in our database. You can also find out about relevant Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed Drugs and Medications on this site too.

Showing "Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed" PubMed Articles 1–25 of 17,000+

Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study.

To assess late toxicity, quality of life and oncological outcome after consolidative whole abdominal radiotherapy (WART) following cytoreductive surgery and carboplatin/paclitaxel chemotherapy in high risk patients with advanced ovarian cancer FIGO stage III using IMRT (Intensity modulated radiation therapy).

Use of intensity-modulated radiation therapy for nasopharyngeal cancer in Japan: analysis using a national database.

Intensity-modulated radiation therapy (IMRT) yields better outcomes and fewer toxicities for radiation therapy (RT) of head and neck cancers (HNCs), including nasopharyngeal cancer (NPC). IMRT is the standard RT treatment and has been widely adopted in Western countries to treat HNCs. However, its uptake in clinical practice among NPC patients has never been studied.

Radiation Therapy for Pediatric Brain Tumors using Robotic Radiation Delivery System and Intensity Modulated Proton Therapy.

This study recruited two centers with expertise in treating pediatric brain tumors with robotic radiation delivery system photon therapy and proton therapy, respectively, to study the plan quality and the dose deposition characteristics of robotic radiation delivery system photon and intensity modulated proton therapy (IMPT) plans.

Sparing Cardiac Substructures with Optimized Volumetric Modulated Arc Therapy and Intensity-Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-Small Cell Lung Cancer.

Increasing radiation dose to the heart is associated with worse survival in stage 3 non-small cell lung cancer (NSCLC). We sought to evaluate the abilities of optimized volumetric modulated arc therapy (VMAT) and intensity-modulated proton therapy (IMPT) to spare cardiac substructures, and sought to determine how a cardiac optimization treatment planning algorithm influences dose distribution to other thoracic organs at risk (OARs).

Efficacy and Tolerance of Intensity Modulated Radiation Therapy for Skull Base Meningioma.

The purpose of this study was to evaluate the efficacy and tolerance of normofractionated stereotactic radiation therapy (RT) and intensity modulated RT with helical tomotherapy for skull base meningioma.

Efficacy of intensity-modulated radiation therapy for optic nerve sheath meningioma.

The present study examined the efficacy and complications associated with intensity-modulated radiation therapy (IMRT) for optic nerve sheath meningioma (ONSM) in 15 cases and compared visual function before and after treatment.

The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.

At present, the management of nasopharyngeal carcinoma (NPC) is mainly based on radiotherapy, but there are many radiation delivery techniques such as intensity-modulated radiotherapy (IMRT) and 2-dimensional radiotherapy (2D-RT).

Secondary cancer risk after Whole-breast radiation therapy: Field-in-Field versus Intensity-Modulated radiation therapy versus Volumetric-Modulated arc therapy.

In this study, we used the concept of organ-equivalent dose (OED) to evaluate the excess absolute risk (EAR) for secondary cancer in various organs after radiation treatment for breast cancer.

Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure.

To assess the long-term outcomes of patients with squamous cell carcinoma of the anal canal (SCCAC) treated with Intensity-Modulated Radiation Therapy (IMRT).

Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.

To view and evaluate the prognosis factors in patients with nasopharyngeal carcinoma (NPC) treated with intensity modulated radiation therapy using nomogram and decision curve analysis (DCA).

Intensity-modulated radiation therapy in breast cancer patients following the release of a Choosing Wisely recommendation.

In 2013, the American Society for Radiation Oncology recommended against the routine use of intensity-modulated radiation therapy (IMRT) in breast cancer patients. We evaluated trends in the use of IMRT before and after the release of the recommendation. Using SEER-Medicare data, we identified 13,457 breast cancer patients diagnosed between 2012 and 2015 who received breast conserving surgery and post-surgery, whole breast, IMRT or three dimensional conformal radiotherapy. We find that the use of IMRT decre...

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in -Mutated Lung Cancer.

Standard first-line therapy for -mutant advanced non-small-cell lung cancer (NSCLC) is an epidermal growth factor receptor (EGFR)-directed oral tyrosine kinase inhibitor. Adding pemetrexed and carboplatin chemotherapy to an oral tyrosine kinase inhibitor may improve outcomes.

Survival After Definitive Chemoradiotherapy With Concurrent Cisplatin or Carboplatin for Head and Neck Cancer.

For definitive chemoradiotherapy (chemoRT) of head and neck squamous cell carcinoma (HNSCC), cisplatin is the preferred concurrent agent, with superiority over cetuximab for HPV-associated oropharyngeal squamous carcinoma recently shown in 2 randomized trials (RTOG 1016 and De-ESCALaTE). Patients who are not candidates for cisplatin may be treated with carboplatin instead, but its comparative efficacy is unclear. We analyzed nationwide patterns of care and cancer-specific outcomes after cisplatin- versus ca...

Intensity-modulated radiotherapy does not decrease the risk of malnutrition in esophageal cancer patients during radiotherapy compared to three-dimensional conformal radiation therapy.

Esophageal cancer is a lethal disease of global scope. Radiotherapy is the main method to treat esophageal cancer; however, it concurrently leads to malnutrition. Intensity-modulated radiotherapy (IMRT) is superior to three-dimensional conformal radiation therapy (3D-CRT) in dosimetry and clinical outcomes. In this cohort study, we aimed to compare the effect of 3D-CRT and IMRT on malnutrition status.

Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.

In 2013, the American Society for Radiation Oncology (ASTRO) issued a Choosing Wisely recommendation against the routine use of intensity modulated radiotherapy (IMRT) for whole breast irradiation. We evaluated IMRT use and subsequent impact on Medicare expenditure in the period immediately preceding this recommendation to provide a baseline measure of IMRT use and associated cost consequences.

Using Robust Optimization for Skin Flashing in Intensity-Modulated Radiotherapy for Breast Cancer Treatment: A Feasibility Study.

To study the feasibility and the effectiveness of a novel implementation of robust optimization on two sets of CT data simultaneously for skin flashing in intensity-modulated radiation therapy for breast cancer.

Radiation Recall Myositis Following Carboplatin/Docetaxel Chemotherapy.

Palliative radiation is an effective form of treatment that can provide meaningful symptom relief in a variety of clinical settings. With continuing advances in clinical therapies, long-term survival after palliative treatment for symptomatic disease is increasingly common, and patients may receive a variety of systemic therapy options following radiation. Here, we report a case and management of radiation recall myositis following administration of carboplatin and docetaxel, a combination which has not pre...

What Neuroradiologists Need to Know About Radiation Treatment for Neural Tumors.

Radiation oncologists and radiologists have a unique and mutually dependent relationship. Radiation oncologists rely on diagnostic imaging to locate the tumor and define the treatment target volume, evaluation of response to therapy, and follow-up. Accurate interpretation of post-treatment imaging requires diagnostic radiologists to have a basic understanding of radiation treatment planning and delivery. There are various radiation treatment modalities such as 3D conformal radiation therapy, intensity modul...

Deep inspiration breath hold intensity modulated radiation therapy in A large clinical series of 239 left sided breast cancer patients: A dosimetric analysis of organs at risk doses and clinical feasibility from a single center experience.

To evaluate dose to organs at risk, target coverage and treatment compliance in left sided breast cancer patients (LSBCP) treated with deep inspiration breath hold (DIBH) and intensity modulated radiation therapy (IMRT) technique in a contest of daily clinical practice.

Dose-volume histogram prediction in volumetric modulated arc therapy for nasopharyngeal carcinomas based on uniform-intensity radiation with equal angle intervals.

In this study, we developed a gated recurrent unit (GRU)-based recurrent neural network (RNN) for dose-volume histogram (DVH) prediction in volumetric modulated arc therapy (VMAT) planning for nasopharyngeal carcinomas (NPCs) based on uniform-intensity radiation with equal angle intervals and investigated the feasibility and usefulness of this method in optimization.

The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study.

To investigate the role of intensity-modulated proton therapy (IMPT) for regional nodal irradiation in patients with breast carcinoma in comparison with volumetric-modulated arc therapy (VMAT).

Treatment-Related Toxicity Using Prostate-Only Versus Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy: A National Population-Based Study.

There is a debate about the effectiveness and toxicity of pelvic lymph node (PLN) irradiation for the treatment of men with high-risk prostate cancer. This study compared the toxicity of intensity-modulated radiation therapy (IMRT) to the prostate and the pelvic lymph nodes (PPLN-IMRT) with prostate-only IMRT (PO-IMRT).

Risk of Pelvic Fracture with Radiation Therapy in Older Patients.

Older patients undergoing radiation therapy (RT) for pelvic malignancies are at increased risk for pelvic fracture, which is associated with significant morbidity and mortality. RT techniques such as brachytherapy or intensity modulated RT (IMRT) allow for more conformal dose distributions, but it is not known whether the risk for pelvic fracture varies by RT modality.

Commercial Insurance Coverage of Advanced Radiotherapy Techniques Compared to American Society for Radiation Oncology Model Policies.

To compare and contrast the American Society for Radiation Oncology (ASTRO) Model Policies (MPs) for intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), stereotactic ablative radiotherapy (SABR), and proton beam therapy (PBT) with the coverage policies constructed by five of the largest publicly-available commercial insurers throughout the United States (Aetna, Anthem, Cigna, Humana, United).

Evolution and Dosimetric Analysis of MRI-detected Brainstem Injury Following Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.

To evaluate the evolution of radiation-induced brainstem injury (BSI) in nasopharyngeal-carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT) and to identify the critical dosimetric predictors of BSI.

Quick Search